Skip to main content
DNA Labs India

NCF1 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

NCF1 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 NGS Genetic Test

Short Name: NCF1 Genetic Test

Also known as: Chronic Granulomatous Disease Type 1, CGD Type 1, Autosomal Recessive CGD

NCF1 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks. Free home collection in 300+ cities across India.

Next-Generation Sequencing (NGS) Genetic TestAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

To diagnose chronic granulomatous disease by detecting pathogenic mutations in the NCF1 gene using next-generation sequencing technology, aiding in clinical management and genetic counseling.

Test Code
4947
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

Clinical history of the patient and a genetic counseling session to draw a pedigree chart of family members affected with granulomatous disease are recommended.

Method: Venipuncture

Step 2

Laboratory Analysis

Blood sample collected via venipuncture or one drop blood on FTA card.

Step 3

Report Delivery

Sample is sent to the laboratory for NGS analysis.

Timeline: 3 to 4 weeks

Patient Instructions

1
Before the Test:Genetic counseling session recommended to discuss test implications and family history.
2
During the Test:Blood sample collection via venipuncture or FTA card.
3
After the Test:Wait for report delivery in 3 to 4 weeks. Follow-up with healthcare provider for interpretation.

About This Test

Who Should Get This Test

To diagnose chronic granulomatous disease by detecting pathogenic mutations in the NCF1 gene using next-generation sequencing technology, aiding in clinical management and genetic counseling.

How to Prepare

  • Ensure proper sample labeling with patient details
  • Avoid hemolysis during blood collection
  • Store sample at ambient room temperature if not processed immediately

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"This test is crucial for diagnosing chronic granulomatous disease and guiding treatment options, especially for patients with recurrent infections and immune deficiencies."

Last medically reviewed: September 3, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs required
ContainerEDTA Tube or FTA Card
Collection MethodVenipuncture

Sample Stability

Blood sample stable for 48 hours at room temperature
Extracted DNA stable for longer periods if stored properly
Sample Rejection Criteria:
  • Insufficient sample volume
  • Hemolyzed or contaminated sample
  • Incorrect sample type

Understanding Your Results

Results indicate the presence or absence of pathogenic variants in the NCF1 gene, which is associated with chronic granulomatous disease.
📊

Positive for pathogenic variant

Diagnosis of NCF1-related granulomatous disease is likely. Genetic counseling and clinical correlation are recommended.

📊

Negative for pathogenic variant

No evidence of NCF1 gene mutation. Consider other genetic or non-genetic causes if symptoms persist.

📊

Variant of uncertain significance

Further testing and family studies may be required for clarification.

⚠️ When to Consult a Doctor:

If symptoms such as chronic infections, skin granulomas, or immune deficiencies are present, or if there is a family history of granulomatous disease.

Limitations

  • May not detect all types of mutations in the NCF1 gene
  • Requires genetic counseling for accurate interpretation
  • Results should be correlated with clinical findings

Risks & Considerations

  • Minimal risk from blood draw, such as bruising or infection
  • Genetic privacy and psychological impact of results

Interfering Factors

  • Sample contamination
  • Degraded DNA quality
  • Improper sample storage

Compare With Similar Tests

TestNCF1 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 NGS Genetic TestCYBB Gene TestImmunodeficiency Panel
ComparisonNCF1 Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b- positive, type 1 NGS Genetic Test

Frequently Asked Questions

What is the NCF1 Gene Test?
It is a genetic test that uses next-generation sequencing to detect mutations in the NCF1 gene, which is associated with chronic granulomatous disease.
Who should consider getting this test?
Individuals with symptoms of chronic granulomatous disease, such as recurrent infections, skin granulomas, or a family history of the condition.
How is the test performed?
A blood sample or extracted DNA is analyzed using NGS technology to identify mutations in the NCF1 gene.
What is the cost of the test?
The test costs INR 20000.0, with home sample collection available across India.
Is home sample collection available?
Yes, DNA Labs India offers free home sample collection for online bookings in many cities across India.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after sample collection.
What do positive results mean?
Positive results indicate the presence of a pathogenic variant in the NCF1 gene, suggesting a diagnosis of chronic granulomatous disease.
Can this test be used for prenatal diagnosis?
It may be used for carrier testing or prenatal diagnosis in families with known mutations, but genetic counseling is essential.
Are there any risks associated with the test?
The test involves minimal risks from blood draw, such as bruising. Genetic testing may have psychological implications.
How accurate is the test?
NGS technology is highly accurate for detecting mutations, but results should be interpreted in conjunction with clinical findings.
What is chronic granulomatous disease?
It is a rare genetic disorder where the immune system cannot effectively fight certain infections, leading to granuloma formation.
How is granulomatous disease treated?
Treatment focuses on managing symptoms with antibiotics, immunosuppressive drugs, and in severe cases, bone marrow transplant.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.